Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design

OBJECTIVE: The safety and feasibility of preoperative pembrolizumab combined with chemoradiotherapy (PPCT) for resectable esophageal squamous cell carcinoma have been confirmed by the prior Preoperative Anti-PD-1 Antibody combined with Chemoradiotherapy for Locally Advanced Squmous Cell Carcinoma of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yuyan, Li, Chengqiang, Yu, Bentong, Zhao, Shengguang, Li, Jian, Chen, Xiaoyan, Li, Hecheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Thoracic: Esophageal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390428/
https://www.ncbi.nlm.nih.gov/pubmed/36003437
http://dx.doi.org/10.1016/j.xjon.2021.11.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390428/
https://www.ncbi.nlm.nih.gov/pubmed/36003437
http://dx.doi.org/10.1016/j.xjon.2021.11.003

Ejemplares similares